Clinical characteristics and outcomes of patients w/COVID-19 and MS on: September 15, 2020, 09:05:44 pm #1 From JAMA Neurology (September 2020), an article entitled "Clinical characteristics and outcomes of patients with [COVID-19] and multiple sclerosis":https://bit.ly/2RzhdRW Logged MS Speaks--online for 20 yearsSPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010. Glatopa (glatiramer acetate 40mg 3 times/week) 12/16/20 - 3/16/24.
